SRT Flashcards

1
Q

Stereotactic definition

A

Precise positioning in a 3 Dimensional plane
Highly precise treatment
Small targets
High dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Principles of Stereotactic

A

Use of multiple non-coplanar beams or
arcs
•Achieves a steep dose gradient -
minimal dose to critical structures and
surrounding healthy tissue
•Achieves conformity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

SRS versus SRT

A

Radiosurgery (SRS)
- Single, high dose of radiation

•Radiotherapy (SRT)
- Treatment is delivered in more
than one fraction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Indications for SRT/SRS

A

•Small tumour size
•Tumour location
•Pathology of the tumour
•The patient
•Tumour recurrence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How does stereotactic work

A

Tumour reduction occurs at the rate of
normal growth for the specific tumour cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Side effects

A

ACUTE: Headache, nausea,
vomiting, visual
disturbances, swelling
(usually managed with
steroids)

•DELAYED: Facial weakness,
numbness, hearing loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Advantages of stereo over VMAT

A

Minimal damage to surrounding tissue
•Treat to higher doses
•Treatment can be given multiple times

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What clinical sites are treated

A

Malignant or benign
Acoustic neuroma
Meningioma
Cranial Mets
GBM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Acoustic neuroma

A

Benign tumour of the 8th
cranial nerve
• Presentation: hearing loss, tinnitus & balance
disturbances
• SRS utilised when surgery risks damage to facial nerves and hearing • SRS12Gy/1#

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Meningioma

A

Usually benign tumour
arising from meningeal
tissue
•Stereotactic for inoperable
or small tumours
•SRS: 18-20Gy
•SRT: 50-60Gy @ 1.8-2Gy/#

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Brain Mets

A

Metastases in the
brain arise from a
variety of primary sites •Patients can present with 1 or many mets •Stereotactic dose of
16
-20Gy/1# per met

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

GBM

A

Highly malignant and fast growing – average survival time 12 months •Symptoms of gliomas may include headaches, nausea, vomiting, seizures, memory loss, changes in speech or personality and walking difficulties •Stereotactic used at time of
recurrence
•SRS: 6
-16Gy/1#

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Planning to treatment workflow

A

MRI
CT Sim
Planning
QA
Treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Why MRI

A

•Essential for all patients
•Provide excellent definition of tumour volume
and critical structures
•Request scans that will best show the target
volume

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Stereo mask

A

Mask made in 20 min
Ensure eyebrows, nose, forehead, cheeks visible
Laterally outer canthus to anterior of Tragus
Two parts - 1 under patients head and one over

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

CT parameters

A

CT – 1mm slices
•Primary image set for planning

17
Q

Planning

A

• Importing of image data sets (MRI + CT)
• Fusion of data sets
• Contouring
• Dosimetry
• RO approval
• Export to treatment

18
Q

Image fusion

A

CT and MRI images are fused together
•CT is always the primary image
•Fusions are automatic, but must be
checked

19
Q

Hyperarc planning

A

Select your treatment targets
•Assign prescribed dose to each target – can have different doses in the same plan
•Isocentre positioned in the middle of single PTV or middle of multiple PTVs
•Set floor and gantry angles
•Floor - 0, 45, 315, 270
•Gantry 360deg or 180deg arcs
•Optimise collimator position

•Enter planning goals into optimiser for PTVs and OARs
•Avoid entry and exit on OARs or previously treated PTVs

Visualise beam/arc to ensure they’re not treating OARs or other PTVs

Reduces collision risks

20
Q

Dose export

A

Once the plan has been approved by the RO it is
exported into:
o MOSAIQ - the R&V system
o ExacTrac - the BrainLAB isocentre positioning
system – Buderim patients

21
Q

Patient pre-treatment prep

A

Single shot patients
• Observations taken
• Nurses tend to administer
Ativan (Lorazepam)
Dexamethasone

22
Q

Treatment times

A

20 - 90 mins

23
Q

What are primary sites for Mets

A

Kidney
Lung
Melanoma
Breast
Colorectal

24
Q

Symptoms of brain cancer

A

Headaches, seizures, dizziness, memory gait, verbal issue, confusion